Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
International
●International Lymphoma Radiation Oncology Group (ILROG): An overview of guidelines for involved site radiation therapy in adult lymphomas (2020)
●Society for Immunotherapy of Cancer (SITC): Clinical practice guideline on immunotherapy for the treatment of lymphoma (2020)
●American Society for Blood and Marrow Transplantation (ASBMT), Center for International Blood and Marrow Transplant Research (CIBMTR), and European Society for Blood and Marrow Transplantation (EBMT): A consensus project on maintenance therapies for Hodgkin and non-Hodgkin lymphomas after autologous transplantation (2019)
●ILROG: Guidelines for the optimal use of imaging in radiation therapy for lymphoma (2019)
●ILROG: Guidelines for proton therapy for adults with mediastinal lymphomas (2018)
●ILROG: Guidelines on the role of radiation therapy in patients with relapsed or refractory Hodgkin lymphoma (2018)
●ILROG: Guidelines on the implementation of contemporary radiation therapy planning concepts for pediatric Hodgkin lymphoma (2015)
●ILROG: Field and dose guidelines for modern radiation therapy for Hodgkin lymphoma (2014)
●Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma – The Lugano classification (2014)
Canada
●Cancer Care Ontario (CCO): Follow-up care for survivors of lymphoma who have received curative-intent treatment (2016)
●CCO: Positron emission tomography in Hodgkin lymphoma patients undergoing curative-intent treatment (2016)
●CCO: Guideline on the management of early-stage Hodgkin lymphoma (2015)
●CCO: The clinical utility of positron emission tomography in the diagnosis, staging, and clinical management of patients with lymphoma – Recommendation report (2015)
United States
●American Society for Blood and Marrow Transplantation (ASBMT), Center for International Blood and Marrow Transplant Research (CIBMTR), and European Society for Blood and Marrow Transplantation (EBMT): A consensus project on maintenance therapies for Hodgkin and non-Hodgkin lymphomas after autologous transplantation (2019)
●ASBMT: Guidelines on the role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma (2015)
Europe
●American Society for Blood and Marrow Transplantation (ASBMT), Center for International Blood and Marrow Transplant Research (CIBMTR), and European Society for Blood and Marrow Transplantation (EBMT): A consensus project on maintenance therapies for Hodgkin and non-Hodgkin lymphomas after autologous transplantation (2019)
●European Society for Medical Oncology (ESMO): Consensus conference on malignant lymphoma – Management of 'ultra-high-risk' patients (2018)
●ESMO: Hodgkin lymphoma – Clinical practice guidelines for diagnosis, treatment and follow-up (2018)
●European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Etude Des Lymphomes De l'Adulte (GELA): Guidelines on the conundrum of hodgkin lymphoma nodes – To be or not to be included in the involved node radiation fields (2008)
United Kingdom
●British Society for Haematology (BSH): Guideline for the first-line management of classical Hodgkin lymphoma (2022)
●British Committee for Standards in Haematology (BCSH): Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma (2016)
India
●Indian Council of Medical Research (ICMR): Consensus document for management of pediatric lymphomas and solid tumors (2017)
Australia–New Zealand
●Choosing Wisely Australia: Limit surveillance computed tomography (CT) scans in asymptomatic patients with confirmed complete remission following curative intent treatment for aggressive lymphoma – except for patients on a clinical trial (2015)
Japan
●[In Japanese] Japanese Society of Pediatric Hematology/Oncology (JSPHO): Clinical guidelines for childhood leukemia/lymphoma, 3rd edition (2016)
